Madrigal Pharmaceuticals, Inc. MDGL Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $232.19M+13.9% | $203.78M-32.2% | $300.69M+57.3% | $191.19M+1.4% | $188.65M+79.6% | ||
| $585.74M-25.4% | $784.87M-3.6% | $814.06M+33.3% | $610.83M-7.4% | $659.42M-20.2% | ||
| $187.36M+39.3% | $134.48M+18.7% | $113.29M+43.0% | $79.23M+29.0% | $61.43M+14.1% | ||
| $112.07M+49.7% | $74.84M+8.0% | $69.32M+9.2% | $63.5M+14.9% | $55.24M+62.1% | ||
| $1.18B-5.1% | $1.25B-7.5% | $1.35B+34.2% | $1B+1.6% | $987.98M-4.4% | ||
| $8.04M+436% | $1.5M-48.5% | $2.91M+80.4% | $1.62M-15.0% | $1.9M-13.2% | ||
| $7.28M-1.3% | $7.38M-1.3% | $7.48M+64.4% | $4.55M-2.0% | $4.64M-1.9% | ||
| $1.23B-2.6% | $1.26B-7.6% | $1.36B+34.2% | $1.02B+1.9% | $996.63M-4.4% | ||
| $60.8M+24.4% | $48.88M+8.8% | $44.94M+18.3% | $37.98M-9.7% | $42.06M-3.5% | ||
| $29.98M— | —— | $31.06M+168% | $11.6M0.0% | $11.6M— | ||
| $338.26M+9.0% | $310.29M-20.7% | $391.41M+99.2% | $196.5M+17.5% | $167.24M-1.2% | ||
| $340.33M+0.1% | $339.88M0.0% | $339.75M+187% | $118.38M+0.3% | $118.01M+0.4% | ||
| $345.61M-0.3% | $346.61M+0.4% | $345.32M+181% | $122.9M+3.5% | $118.76M+0.1% | ||
| $683.87M+4.1% | $656.9M-10.8% | $736.73M+131% | $319.4M+11.7% | $285.99M-0.7% | ||
| 200M0.0% | 200M0.0% | 200M0.0% | 200M0.0% | 200M+9,999,900% | ||
| -$2.18B-4.5% | -$2.09B-2.9% | -$2.03B-6.0% | -$1.92B-2.3% | -$1.88B-4.1% | ||
| $543.45M-9.8% | $602.69M-3.7% | $625.73M-10.1% | $695.98M-2.1% | $710.64M-5.8% | ||
| $1.23B-2.6% | $1.26B-7.6% | $1.36B+34.2% | $1.02B+1.9% | $996.63M-4.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Madrigal Pharmaceuticals, Inc.'s total assets?
- Madrigal Pharmaceuticals, Inc. (MDGL) holds $1.2B in total assets, up 23.2% year over year.
- How much debt does Madrigal Pharmaceuticals, Inc. have?
- Madrigal Pharmaceuticals, Inc. carries $377.3M in total debt against $543.5M of shareholders' equity, a debt-to-equity ratio of 0.69.
- How much cash does Madrigal Pharmaceuticals, Inc. have?
- Madrigal Pharmaceuticals, Inc. holds $232.2M in cash and equivalents.
- Can Madrigal Pharmaceuticals, Inc. cover its short-term obligations?
- Its current ratio is 3.50 — current assets exceed current liabilities.
- Where does Madrigal Pharmaceuticals, Inc.'s balance sheet data come from?
- Every line is extracted from Madrigal Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
